Skip to main content
SpringerLink
Log in
Book cover

Gastrointestinal Malignancies pp 233–256Cite as

Locoregional Therapies for Primary and Secondary Hepatic Malignancies

  • Chapter
  • First Online:

Part of the book series: Cancer Treatment and Research ((CTAR))

Abstract

Management of hepatic malignancies is a multidisciplinary task with the involvement of hepatologists, medical/surgical oncologists, transplant surgeons, and interventional radiologists. The patients should be selected for a specific targeted therapy after multidisciplinary consensus. Interventional oncology has established its role in the management of hepatic malignancies. Image-guided locoregional therapies decrease the rate of systemic toxicity without compromising tumoricidal effect.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. El-Serag HB (2002) Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 36:S74–S83

    Article  PubMed  Google Scholar 

  2. Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693–699

    Article  CAS  PubMed  Google Scholar 

  3. Lewandowski RJ, Kulik LM, Riaz A et al (2009) A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant 9:1920–1928

    Article  CAS  PubMed  Google Scholar 

  4. Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378–390

    Article  CAS  PubMed  Google Scholar 

  5. Kulik LM, Carr BI, Mulcahy MF et al (2007) Safety and efficacy of (90)Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology 47:71–81

    Article  Google Scholar 

  6. Welsh JS, Kennedy AS, Thomadsen B (2006) Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Int J Radiat Oncol Biol Phys 66:S62–S73

    Article  CAS  PubMed  Google Scholar 

  7. Hickey R, Lewandowski R, Salem R (2015) Yttrium-90 radioembolization is a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases: further evidence in support of a new treatment paradigm. Ann Surg Oncol 22:706–707

    Article  PubMed  Google Scholar 

  8. Riaz A, Ryu RK, Kulik LM et al (2009) Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival. J Clin Oncol 27:5734–5742

    Article  CAS  PubMed  Google Scholar 

  9. Ibrahim SM, Nikolaidis P, Miller FH et al (2008) Radiologic findings following Y90 radioembolization for primary liver malignancies. Abdom Imaging

    Google Scholar 

  10. Rhee TK, Naik NK, Deng J et al (2008) Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging. J Vasc Interv Radiol 19:1180–1186

    Article  PubMed  Google Scholar 

  11. Markowitz J (1952) The hepatic artery. Surg Gynecol Obstet 95:644–646

    CAS  PubMed  Google Scholar 

  12. Erler JT, Bennewith KL, Nicolau M et al (2006) Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440:1222–1226

    Article  CAS  PubMed  Google Scholar 

  13. Brown KT, Nevins AB, Getrajdman GI et al (1998) Particle embolization for hepatocellular carcinoma. J Vasc Interv Radiol 9:822–828

    Article  CAS  PubMed  Google Scholar 

  14. Camma C, Schepis F, Orlando A et al (2002) Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 224:47–54

    Article  PubMed  Google Scholar 

  15. Bruix J, Llovet JM, Castells A et al (1998) Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 27:1578–1583

    Article  CAS  PubMed  Google Scholar 

  16. Maluccio MA, Covey AM, Porat LB et al (2008) Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol (in press)

    Google Scholar 

  17. Maluccio MA, Covey AM, Schubert J et al (2006) Treatment of metastatic sarcoma to the liver with bland embolization. Cancer 107:1617–1623

    Article  PubMed  Google Scholar 

  18. Xia J, Ren Z, Ye S et al (2006) Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer. Eur J Radiol

    Google Scholar 

  19. Coldwell DM, Stokes KR, Yakes WF (1994) Embolotherapy: agents, clinical applications, and techniques. Radiographics 14:623–43 (quiz 645-6)

    Google Scholar 

  20. Llovet JM, Real MI, Montana X et al (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359:1734–1739

    Article  PubMed  Google Scholar 

  21. Takayasu K, Arii S, Ikai I et al (2006) Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131:461–469

    Article  CAS  PubMed  Google Scholar 

  22. Geschwind J, Hong K, Georgiades C (2006) Utility of transcatheter arterial chemoembolization for liver dominant colorectal metastatic adenocarcinoma in the salvage setting. American Society of Clinical Oncology Gastrointestinal Cancers Symposium. San Francisco, CA, 26–28 Jan 2006

    Google Scholar 

  23. Liapi E, Geschwind J-F, Vossen JA et al (2008) Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization. Am J Roentgenol 190:67–73

    Article  Google Scholar 

  24. Giroux MF, Baum RA, Soulen MC (2004) Chemoembolization of liver metastasis from breast carcinoma. J Vasc Interv Radiol 15:289–291

    Article  PubMed  Google Scholar 

  25. Buijs M, Kamel IR, Vossen JA et al (2007) Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging. J Vasc Interv Radiol 18:957–963

    Article  PubMed  Google Scholar 

  26. Burger I, Hong K, Schulick R et al (2005) Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J Vasc Interv Radiol 16:353–361

    Article  PubMed  Google Scholar 

  27. Murakami T, Ishimaru H, Sakamoto I et al (2007) Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence. Cardiovasc Interv Radiol 30:696–704

    Article  Google Scholar 

  28. Cheng BQ, Jia CQ, Liu CT et al (2008) Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA 299:1669–1677

    Article  CAS  PubMed  Google Scholar 

  29. Heckman JT, Devera MB, Marsh JW et al (2008) Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. Ann Surg Oncol 15:3169–3177

    Article  PubMed  Google Scholar 

  30. Bartolozzi C, Lencioni R, Caramella D et al (1995) Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology 197:812–818

    Article  CAS  PubMed  Google Scholar 

  31. Kim HK, Chung YH, Song BC et al (2001) Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma. J Clin Gastroenterol 32:423–427

    Article  CAS  PubMed  Google Scholar 

  32. Belli L, Magistretti G, Puricelli GP et al (1997) Arteritis following intra-arterial chemotherapy for liver tumors. Eur Radiol 7:323–326

    Article  CAS  PubMed  Google Scholar 

  33. Hong K, Georgiades CS, Geschwind JF (2006) Technology insight: Image-guided therapies for hepatocellular carcinoma—intra-arterial and ablative techniques. Nat Clin Pract Oncol 3:315–324

    Article  PubMed  Google Scholar 

  34. Varela M, Real MI, Burrel M et al (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46:474–481

    Article  CAS  PubMed  Google Scholar 

  35. Constantin M, Fundueanu G, Bortolotti F et al (2004) Preparation and characterisation of poly(vinyl alcohol)/cyclodextrin microspheres as matrix for inclusion and separation of drugs. Int J Pharm 285:87–96

    Article  Google Scholar 

  36. Gonzalez MV, Tang Y, Phillips GJ et al (2007) Doxorubicin eluting beads-2: methods for evaluating drug elution and in-vitro:in-vivo correlation. J Mater Sci Mater Med

    Google Scholar 

  37. Lo CM, Ngan H, Tso WK et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164–1171

    Article  CAS  PubMed  Google Scholar 

  38. Taylor RR, Tang Y, Gonzalez MV et al (2007) Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties. Eur J Pharm Sci 30:7–14

    Article  CAS  PubMed  Google Scholar 

  39. Covey AM, Brody LA, Maluccio MA et al (2002) Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients. Radiology 224:542–547

    Article  PubMed  Google Scholar 

  40. Gates VL, Marshall KG, Salzig K et al (2014) Outpatient single-session yttrium-90 glass microsphere radioembolization. J Vasc Interv Radiol 25:266–270

    Article  PubMed  Google Scholar 

  41. Salem R, Thurston KG, Carr BI et al (2002) Yttrium-90 microspheres: radiation therapy for unresectable liver cancer. J Vasc Interv Radiol 13:S223–S229

    Article  PubMed  Google Scholar 

  42. Raoul JL, Guyader D, Bretagne JF et al (1997) Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma. Hepatology 26:1156–1161

    CAS  PubMed  Google Scholar 

  43. Kumar A, Srivastava DN, Chau TT et al (2007) Inoperable hepatocellular carcinoma: transarterial 188Re HDD-labeled iodized oil for treatment–prospective multicenter clinical trial. Radiology 243:509–519

    Article  PubMed  Google Scholar 

  44. Wong JY, Somlo G, Odom-Maryon T et al (1999) Initial clinical experience evaluating Yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancer. Clin Cancer Res 5:3224s–3231s

    CAS  PubMed  Google Scholar 

  45. Kim JK, Han KH, Lee JT et al (2006) Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166/chitosan complex (Milican) for the treatment of small hepatocellular carcinoma. Clin Cancer Res 12:543–548

    Article  CAS  PubMed  Google Scholar 

  46. Vouche M, Lewandowski RJ, Atassi R et al (2013) Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J Hepatol 59:1029–1036

    Article  PubMed  Google Scholar 

  47. Riaz A, Gates VL, Atassi B et al (2011) Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization. Int J Radiat Oncol Biol Phys 79:163–171

    Article  PubMed  Google Scholar 

  48. Kulik LM, Atassi B, van Holsbeeck L et al (2006) Yttrium-90 microspheres (TheraSphere(R)) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation. J Surg Oncol 94:572–586

    Article  CAS  PubMed  Google Scholar 

  49. Ibrahim SM, Mulcahy MF, Lewandowski RJ et al (2008) Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study. Cancer

    Google Scholar 

  50. van Hazel GA, Pavlakis N, Goldstein D et al (2009) Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy. J Clin Oncol 27:4089–4095

    Article  PubMed  Google Scholar 

  51. Gray B, Van Hazel G, Hope M et al (2001) Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 12:1711–1720

    Article  CAS  PubMed  Google Scholar 

  52. Kennedy A, Coldwell D, Nutting C et al (2005) Liver Brachytherapy for Unresectable Colorectal Metastases: US Results 2000–2004. In: ASCO GI Symposium, Miami, Florida, 27–29 Jan 2005

    Google Scholar 

  53. Goin JE, Dancey JE, Hermann GA et al (2003) Treatment of unresectable metastatic colorectal carcinoma to the liver with intrahepatic Y-90 microspheres: a dose-ranging study. World J Nuc Med 2:216–225

    Google Scholar 

  54. Rhee TK, Lewandowski RJ, Liu DM et al (2008) 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience. Ann Surg 247:1029–1035

    Article  PubMed  Google Scholar 

  55. Kennedy AS, Dezarn WA, McNeillie P et al (2008) Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients. Am J Clin Oncol 31:271–279

    Article  PubMed  Google Scholar 

  56. Coldwell D, Nutting C, Kennedy AK (2005) Treatment of hepatic metastases from breast cancer with Yttrium-90 SIR-Spheres radioembolization. In: Society of Interventional Radiology Annual Meeting, New Orleans, LA, March 31–April 5 2005

    Google Scholar 

  57. Sato KT, Lewandowski RJ, Mulcahy MF et al (2008) Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres–safety, efficacy, and survival. Radiology 247:507–515

    Article  PubMed  Google Scholar 

  58. Salem R, Lewandowski RJ, Atassi B et al (2005) Treatment of unresectable hepatocellular carcinoma with use of 90Y Microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 16:1627–1639

    Article  PubMed  Google Scholar 

  59. Kennedy AS, Coldwell D, Nutting C et al (2006) Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 65:412–425

    Article  CAS  PubMed  Google Scholar 

  60. Murthy R, Xiong H, Nunez R et al (2005) Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol 16:937–945

    Article  PubMed  Google Scholar 

  61. Sangro B, Gil-Alzugaray B, Rodriguez J et al (2008) Liver disease induced by radioembolization of liver tumors: description and possible risk factors. Cancer 112:1538–1546

    Article  PubMed  Google Scholar 

  62. Young JY, Rhee TK, Atassi B et al (2007) Radiation Dose Limits and Liver Toxicities Resulting from Multiple Yttrium-90 Radioembolization Treatments for Hepatocellular Carcinoma. J Vasc Interv Radiol 18:1375–1382

    Article  PubMed  Google Scholar 

  63. Jakobs TF, Saleem S, Atassi B et al (2008) Fibrosis, Portal Hypertension, and Hepatic Volume Changes Induced by Intra-arterial Radiotherapy with (90)Yttrium Microspheres. Dig Dis Sci 53:2556–2563

    Article  CAS  PubMed  Google Scholar 

  64. Leung TW, Lau WY, Ho SK et al (1995) Radiation pneumonitis after selective internal radiation treatment with intraarterial 90 yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys 33:919–924

    Article  CAS  PubMed  Google Scholar 

  65. TheraSphere Yttrium-90 microspheres package insert, MDS Nordion, Kanata, Canada, 2004

    Google Scholar 

  66. Murthy R, Brown DB, Salem R et al (2007) Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. J Vasc Interv Radiol 18:553–61 (quiz 562)

    Google Scholar 

  67. Carretero C, Munoz-Navas M, Betes M et al Gastroduodenal injury after radioembolization of hepatic tumors. Am J Gastroenterol

    Google Scholar 

  68. Murthy R, Eng C, Krishnan S et al (2007) Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab. J Vasc Interv Radiol 18:1588–1591

    Article  PubMed  Google Scholar 

  69. Lencioni R, Crocetti L (2007) Radiofrequency ablation of liver cancer. Tech Vasc Interv Radiol 10:38–46

    Article  PubMed  Google Scholar 

  70. Sironi S, Livraghi T, Meloni F et al (1999) Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up. AJR Am J Roentgenol 173:1225–1229

    Article  CAS  PubMed  Google Scholar 

  71. Goldberg SN, Grassi CJ, Cardella JF et al (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235:728–739

    Article  PubMed  PubMed Central  Google Scholar 

  72. Mazzaglia PJ, Berber E, Milas M et al (2007) Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival. Surgery 142:10–19

    Article  PubMed  Google Scholar 

  73. Shock SA, Laeseke PF, Sampson LA et al (2005) Hepatic hemorrhage caused by percutaneous tumor ablation: radiofrequency ablation versus cryoablation in a porcine model. Radiology 236:125–131

    Article  PubMed  Google Scholar 

  74. Hinshaw JL, Lee FT Jr (2007) Cryoablation for liver cancer. Tech Vasc Interv Radiol 10:47–57

    Article  PubMed  Google Scholar 

  75. Goldberg SN, Grassi CJ, Cardella JF et al (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 16:765–778

    Article  PubMed  Google Scholar 

  76. Dodd GD 3rd, Napier D, Schoolfield JD et al (2005) Percutaneous radiofrequency ablation of hepatic tumors: postablation syndrome. AJR Am J Roentgenol 185:51–57

    Article  PubMed  Google Scholar 

  77. Liang P, Dong B, Yu X et al (2001) Computer-aided dynamic simulation of microwave-induced thermal distribution in coagulation of liver cancer. IEEE Trans Biomed Eng 48:821–829

    Article  CAS  PubMed  Google Scholar 

  78. Dong B, Liang P, Yu X et al (2003) Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. AJR Am J Roentgenol 180:1547–1555

    Article  PubMed  Google Scholar 

  79. Kamel IR, Reyes DK, Liapi E et al (2007) Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma. J Vasc Interv Radiol 18:49–56

    Article  PubMed  Google Scholar 

  80. Shibata T, Iimuro Y, Yamamoto Y et al (2002) Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 223:331–337

    Article  PubMed  Google Scholar 

  81. Nakamura H, Kawasaki N, Hagiwara M et al (2001) Early hilar lung cancer–risk for multiple lung cancers and clinical outcome. Lung Cancer 33:51–57

    Article  CAS  PubMed  Google Scholar 

  82. Pacella CM, Bizzarri G, Cecconi P et al (2001) Hepatocellular carcinoma: long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization. Radiology 219:669–678

    Article  CAS  PubMed  Google Scholar 

  83. Nolsoe CP, Torp-Pedersen S, Burcharth F et al (1993) Interstitial hyperthermia of colorectal liver metastases with a US-guided Nd-YAG laser with a diffuser tip: a pilot clinical study. Radiology 187:333–337

    Article  CAS  PubMed  Google Scholar 

  84. Vogl TJ, Schwarz W, Eichler K et al (2006) Hepatic intraarterial chemotherapy with gemcitabine in patients with unresectable cholangiocarcinomas and liver metastases of pancreatic cancer: a clinical study on maximum tolerable dose and treatment efficacy. J Cancer Res Clin Oncol 132:745–755

    Article  CAS  PubMed  Google Scholar 

  85. Mack MG, Straub R, Eichler K et al (2004) Breast cancer metastases in liver: laser-induced interstitial thermotherapy–local tumor control rate and survival data. Radiology 233:400–409

    Article  PubMed  Google Scholar 

  86. Delabrousse E, Mithieux F, Birer A et al (2008) Percutaneous sonographically guided interstitial US ablation: experimentation in an In Vivo Pig Liver Model. J Vasc Interv Radiol

    Google Scholar 

  87. Zhang L, Zhu H, Jin C et al (2008) High-intensity focused ultrasound (HIFU): effective and safe therapy for hepatocellular carcinoma adjacent to major hepatic veins. Eur Radiol

    Google Scholar 

  88. Wu F, Wang ZB, Chen WZ et al (2005) Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology 235:659–667

    Article  PubMed  Google Scholar 

  89. Atwell TD, Charboneau JW, Que FG et al (2005) Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques. Cardiovasc Intervent Radiol 28:409–421

    Article  CAS  PubMed  Google Scholar 

  90. Nair RT, Silverman SG, Tuncali K et al (2008) Biochemical and hematologic alterations following percutaneous cryoablation of liver tumors: experience in 48 procedures. Radiology 248:303–311

    Article  PubMed  Google Scholar 

  91. Zardi EM, Di Matteo F, Santini D et al (2008) Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature. J Exp Clin Cancer Res 27:28

    Article  PubMed  PubMed Central  Google Scholar 

  92. Lencioni RA, Allgaier HP, Cioni D et al (2003) Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228:235–240

    Article  PubMed  Google Scholar 

  93. Di Stasi M, Buscarini L, Livraghi T et al (1997) Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates. Scand J Gastroenterol 32:1168–1173

    Article  PubMed  Google Scholar 

  94. Ohnishi K, Ohyama N, Ito S et al (1994) Small hepatocellular carcinoma: treatment with US-guided intratumoral injection of acetic acid. Radiology 193:747–752

    Article  CAS  PubMed  Google Scholar 

  95. Ohnishi K, Yoshioka H, Ito S et al (1998) Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 27:67–72

    Article  CAS  PubMed  Google Scholar 

  96. Rubinsky B, Onik G, Mikus P (2007) Irreversible electroporation: a new ablation modality–clinical implications. Technol Cancer Res Treat 6:37–48

    Article  PubMed  Google Scholar 

  97. Cannon R, Ellis S, Hayes D et al (2013) Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol 107:544–549

    Article  PubMed  Google Scholar 

  98. Lu DS, Yu NC, Raman SS et al (2005) Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 41:1130–1137

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Section of Interventional Radiology, Robert H Lurie Comprehensive Cancer Center, Northwestern University, 676 N. St, Clairchicago, IL, 60611, USA

    Ahsun Riaz, Robert J. Lewandowski & Riad Salem

Authors
  1. Ahsun Riaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert J. Lewandowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Riad Salem
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ahsun Riaz .

Editor information

Editors and Affiliations

  1. Department of Surgery, Northwestern University, Chicago, Illinois, USA

    David Bentrem

  2. Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois, USA

    Al B. Benson

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Riaz, A., Lewandowski, R.J., Salem, R. (2016). Locoregional Therapies for Primary and Secondary Hepatic Malignancies. In: Bentrem, D., Benson, A. (eds) Gastrointestinal Malignancies. Cancer Treatment and Research. Springer, Cham. https://doi.org/10.1007/978-3-319-34244-3_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-34244-3_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-34242-9

  • Online ISBN: 978-3-319-34244-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation